Bioanalysis Zone

Development of an early stage biomarker within discovery: Considerations for assay requirements


View webinar on demand

Early-stage biomarker assay development and validation plays an increasingly important role in drug discovery and development. But as ever-changing regulatory guidelines push pharmacodynamics (PD) and safety endpoint data requirements to new degrees of sensitivity, the demand for developing fit-for-purpose biomarker assays presents new challenges to drug developers and regulators alike.
In this webinar, Adrian Freeman, Head of Biomarkers Bioanalysis and Clinical Services, shares a story of how Envigo developed a novel biomarker assay that takes assay endpoint requirements into consideration in his presentation ‘Development of an early stage biomarker within discovery: Considerations for assay requirements.
This insightful webinar will provide a behind-the-scenes perspective into the bioassay development as well as:
• Examine the biology and measurement of thyroid hormones
• Discuss the considerations and parameters used for the development of a biomarker assay
• Discover the positive outcome of collaboration among CROs, regulators and instrument / kit manufacturers

Discover early-stage biomarker development and more!


Leave A Comment

Please wait...

Bioanalysis Zone New Investigator Award

Why not start this year by doing something good by nominating an early career scientist for the Bioanalysis Zone New Investigator Award. Complete the details below to register your interest!